1.
2.
3.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
4.
Revolution Medicines Draws Takeover Interest
(feeds.content.dowjones.io)
5.
AbbVie Near Deal for Revolution Medicines
(feeds.content.dowjones.io)